Home Topics OMICs miRNA BIOMARKERS FOR DRUG-INDUCED LIVER INJURY miRNA BIOMARKERS FOR DRUG-INDUCED LIVER INJURY March 12, 2009 – Interview with David Galas, Ph.D., Senior Vice President of Strategic Partnerships, Institute for Systems Biology /wp-content/uploads/2018/09/gc254_3_12_2009.mp3 PodcastsResourcesBiomarkersCellular, Molecular and Developmental BiologyComputational biologyDiagnosisDrug-induced liver injuryHepatic injuryMedicine, Diagnosis, and TherapeuticsmiRNA (RNA isoforms)Molecular biologyMolecular biomarkerOrgan injuryRNA biologyRNA biomarkerRNA isoformsSystemic conditionsSystems biologyTechnology and Computational BiologyTrauma and injury Also of Interest HIV-Free Hopes Raised by Reservoir-Targeting VLPs Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline StockWatch: CDMOs Tumble as Congress Takes Aim at Chinese Biotechs Single Motor Neurons Analyzed in 3D in a Moving Fly Body GTC 2024: Nvidia’s Quantum Expansion Runs through the Cloud Related Media Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Emerging Markets Collaborate to Succeed in Post-Pandemic World The Sun Sets on AGBT: A Report from the Last Day Spatial, Sequencing, and Sun: A Report from Day 2 of AGBT Sand, Sea, and Sequencing: Julianna LeMieux Surfs up AGBT's Hot News Related Content HIV-Free Hopes Raised by Reservoir-Targeting VLPs Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline StockWatch: CDMOs Tumble as Congress Takes Aim at Chinese Biotechs